The risk of developing epilepsy in patients with
gliomas or neuroepithelial tumours is extremely significant.
Low-grade and high-grade gliomas are the two types of
gliomas. Low-grade brain tumours, as well as tumours
located in the temporal and insular cortex, have a higher
proclivity for developing epilepsy. Seizure control is much
improved by surgical treatment of the tumour, particularly
gross tumour removal, especially in neuroglial tumours.
Low-grade gliomas are more likely to cause refractory
epilepsy, with 30–35 percent experiencing it. The therapy
of combined drug-induced gingival expansion in a patient
surgically treated for low-grade glioma is described in this